Skip to Content
AOPMC
Main Content


Abstract Submissions

Official notifications regarding the status of abstract submissions for the 8th AOPMC have been sent by our submission site, CATALYST by Omnipress. An official abstract notification letter is also available through the submission site and can be downloaded and printed at any time.

 

Abstract Presentation

All accepted abstracts will be presented as a printed poster during designated times of the 8th AOPMC. 

Poster Orientation: Vertical 

Poster Size: Posters must fit within the size allotment of the poster display boards, 1 meter (width) x 2.4m (height). It is strongly encouraged the printed size of your poster be no larger than 800mm (width) x 2000mm (height) to account for poster numbers and poster board edges. 

Font Size: Please print your poster text large enough to be easily read at a distance of approximately 1.5 meters (5 feet) 

Content: Posters should include a short and comprehensive review of the basic items of the study. This can be done by dividing text into several clear sections including: title and authors, background, case reports/material/methods, figures/graphs/photos, results, conclusions, and major references 

Language: All posters must be printed and presented in English.

Daily poster presentations will be scheduled Friday and Saturday during the 2023 AOPMC. A detailed schedule, including poster set up and removal times, will be included in the abstract acceptance notification for each poster.

Note: Accepted abstract presenters should plan to attend the 2023 AOPMC for the duration of the meeting, from March 17-19, 2023, as poster presentation dates are subject to change.

All abstract presenters are required to register and pay applicable registration fees to attend the 8th AOPMC. It is not mandatory that the first author is pre-registered; the presenter can be any of the contributing authors or a colleagu


Submission Guidelines

Open AllClose All
Abstract Submission Guidelines

Abstract submission deadline: October 17, 2022, 11:59PM CST. 


An individual may be the first author on a maximum of three (3) abstracts. 
An individual may be a contributing author on an unlimited number of abstracts. 
All submitted abstracts become the property of MDS. 

Format

Text limit of 2,500 characters (including spaces). The size limit includes characters and spaces in the Abstract Title and Abstract Body. Please note that spaces are included in the overall character count. The size limit does not include author information. 

Abstracts should be arranged as follows:

  • Objective
  • Background
  • Methods
  • Results
  • Conclusions

*You may submit a case report using the standard abstract format

Do not include any identifying information directly on the abstract. 

Drug names: Only non-proprietary (generic) drug names should be used and should be written without capitals. Do not include branded product names in the abstract. If the abstract is found to contain marketing, rather than scientific content, the abstract will be rejected. 

Categories: Select one (1) category under which the abstract should be reviewed. If the abstract covers more than one topic, please choose the most appropriate category.

Abbreviations: Use standard abbreviations. A special or unusual abbreviation should be placed in parentheses after the first appearance of the full word for which it stands. 

Tables and graphs: There is a separate upload field for tables and graphs. To include tables or figures, enter the appropriate ID tag within the abstract body where the tables and/or figures should appear. Tags must be entered as shown: 

  • [table1] for your first table
  • [table2] for your second table
  • [figure1] for your first figure
  • [figure2] for your second figure.

Reference IDs: To list references, enter the appropriate ID tag: 

  • [1] for your first reference
  • [2] for your second reference
  • [3] for your third reference
  • etc. 
Submission

The sole means of submission is via the Internet. Please do not e-mail, fax, or mail abstract submissions.

Eligibility

Abstracts must be submitted and presented in English. 
MDS members and non-members are eligible to submit abstracts.
There is no fee for submitting an MDS abstract.
MDS does not offer CME credit for poster viewing or submitted abstracts. 
AOPMC faculty are not required to submit an abstract. 

MDS expects that all accepted abstracts will be presented during the scheduled poster session time during the 8th AOPMC and that no submitted abstracts will be withdrawn. Please do not submit an abstract unless you are prepared to travel to the 8th AOPMC to present your abstract as a printed poster as scheduled by MDS.

All abstract presenters are required to register and pay applicable registration fees to attend the AOPMC.

Previously Published Abstracts and Plagiarism

All submitted abstracts will be run through an online plagiarism detection software. Should plagiarism be detected, the abstract will be rejected. 

Abstracts that have been presented at other meetings may be submitted if they have not been previously published. Submitted abstracts that have been presented at other meetings must include the previous meeting name and presentation date cited accordingly in the abstract body, after the Conclusion.

If the abstract is found to have been previously published in another MDS publication or a previous edition of the Movement Disorders journal, the designated contact person will be notified and required to revise the abstract, or the abstract will be rejected. 

All abstracts presented at a previous MDS International Congress or MDS regional meeting, such as the AOPMC or PAS Congress, have been published by MDS.

MDS does not republish previously published abstracts. 

Review and Categorization

The AOPMC Scientific Program Committee will review all abstracts in November of 2022. The Committee shall be directed to reject abstracts for the following reasons:

  • Plagiarism detected
  • Marketing detected 
  • Subject not related to the field of Movement Disorders
  • Does not meet basic requirements

All submitted abstracts will be run through an online plagiarism detection software. Should plagiarism be detected, the abstract will be rejected. 

E-booklet PDF Submission

Please visit https://catalyst.omnipress.com by January 31, 2023 to view and submit a PDF of your poster for inclusion in an online supplement booklet. All supplemental booklet materials are due January 31, 2023 (extensions will not be granted). 

Format: Only PDF files will be accepted.  
Number of pages: PDF poster must be kept to 1 page per abstract.  
File size: 150 MB maximum file size.  
Content: PDF must include the corresponding abstract as accepted, without changes that modify the outcome of the originally submitted abstract. Please ensure poster content is scientific in nature and refrain from including marketing or promotional materials.

Open AllClose All
Notification and Correspondence

All notifications regarding a saved or submitted abstract will be sent only to the person identified as ‘Contact for Official Abstract Correspondence.’ It is expected that the designated contact person will circulate updates regarding the abstract as needed. 

All successfully submitted abstracts will receive a confirmation e-mail to the designated contact person. If the confirmation e-mail has not been received within 24-hours of submitting the abstract, please log in to the abstract submission site to verify the status of the submission. 

Abstract acceptance notifications will be sent to the designated contact person via e-mail in early December 2022.

An official abstract notification letter will be available through the submission site and can be downloaded and printed at any time after notifications have been sent in early December 2022.

All confirmed abstract submissions will be reviewed for acceptance by MDS. 

Abstracts with a status of ‘saved’ are not confirmed submissions and will not be reviewed by MDS. 

Please ensure that noreply@omnipress.com and aopmc@movementdisorders.org are designated as a “safe sender” to ensure timely correspondence regarding the abstract submission.

Please check your spam and junk e-mail folders before contacting MDS regarding the status of your abstract. Abstract notices will come from noreply@omnipress.com or aopmc@movementdisorders.org.

Abstract status can also be checked directly on the submission site in early December 2022.

Withdrawing a Submitted Abstract

July 1, 2022 - October 17, 2022
You may withdraw a submitted abstract at any time while submission is still open (before October 17, 2022). To withdraw an abstract, simply log in to your submission and click on 'Withdraw'. There is no penalty to withdraw your abstract.
 
October 17, 2022 - January 31, 2023 
Requests to withdraw a submitted abstract after the submission deadline (October 17, 2022) must be received in writing by  January 31, 2023, to aopmc@movementdisorders.org.
 
January 31, 2023 - Onward
After January 31, 2023, your abstract cannot be withdrawn and will remain a part of the 8th AOPMC abstract publication in an electronic supplement to the Movement Disorders Clinical Practice journal, online edition. All submitted abstracts become the property of MDS.  
 

Publication of Accepted Abstracts

All accepted abstracts will be published in an electronic supplement to the Movement Disorders Clinical Practice journal online edition. All submitted abstracts become the property of MDS.

MDS only accepts original work. By submitting your abstract, you affirm that your abstract is your own, either individually or as a group. Should plagiarism be detected, the abstract will be rejected. 

Abstract Presentation

All accepted abstracts will be presented as a printed poster during designated times of the 8th AOPMC. Please check back to www.aopmc.org/abstracts for updates and specific information regarding poster size and layout. 

Daily poster presentations will be scheduled Friday and Saturday during the 2023 AOPMC. A detailed schedule, including poster set up and removal times, will be included in the abstract acceptance notification for each poster. The general poster presentation and viewing schedule can be found on the AOPMC website in December 2022.

Note: Accepted abstract presenters should plan to attend the 2023 AOPMC for the duration of the meeting, from March 17-19, 2023, as poster presentation dates are subject to change.

 

All abstract presenters are required to register and pay applicable registration fees to attend the 8th AOPMC. It is not mandatory that the first author is pre-registered; the presenter can be any of the contributing authors or a colleague

Travel Grants

Support for authors with financial need to travel to and participate in the AOPMC. 

Application deadline: October 17, 2022

Learn more

Junior Awards

Awarded to young abstract authors for significant contribution to clinical and basic science research.

Application deadline: October 17, 2022

Learn more

 

Questions?

Feel free to contact the MDS International Secretariat at aopmc@movementdisorders.org.

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice